Sotera Health (NASDAQ:SHC) Receives Average Rating of "Moderate Buy" from Brokerages

Sotera Health (NASDAQ:SHC - Get Free Report) has received an average rating of "Moderate Buy" from the seven brokerages that are covering the firm, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $16.08.

A number of equities analysts have recently weighed in on the company. Royal Bank of Canada reiterated an "outperform" rating and issued a $17.00 target price on shares of Sotera Health in a report on Thursday, November 21st. Citigroup upped their target price on Sotera Health from $18.00 to $20.00 and gave the stock a "buy" rating in a research report on Wednesday, November 6th. Finally, The Goldman Sachs Group started coverage on shares of Sotera Health in a research note on Friday, December 6th. They issued a "neutral" rating and a $14.00 target price for the company.

Institutional Trading of Sotera Health

Several large investors have recently modified their holdings of SHC. Blue Trust Inc. boosted its holdings in Sotera Health by 164.3% during the fourth quarter. Blue Trust Inc. now owns 1,834 shares of the company's stock valued at $25,000 after acquiring an additional 1,140 shares during the period. True Wealth Design LLC bought a new stake in Sotera Health during the 3rd quarter valued at approximately $32,000. GAMMA Investing LLC boosted its stake in Sotera Health by 125.0% during the 3rd quarter. GAMMA Investing LLC now owns 2,988 shares of the company's stock valued at $50,000 after purchasing an additional 1,660 shares during the period. Capital Performance Advisors LLP acquired a new stake in Sotera Health in the 3rd quarter valued at approximately $91,000. Finally, Point72 DIFC Ltd increased its position in Sotera Health by 556.6% in the 2nd quarter. Point72 DIFC Ltd now owns 6,540 shares of the company's stock worth $78,000 after buying an additional 5,544 shares during the period. 91.03% of the stock is owned by institutional investors.

Sotera Health Price Performance

Shares of SHC traded down $0.17 during trading hours on Tuesday, hitting $13.79. 492,659 shares of the company were exchanged, compared to its average volume of 879,382. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61. The company has a market capitalization of $3.90 billion, a PE ratio of 55.17 and a beta of 1.92. The firm has a fifty day simple moving average of $13.30 and a 200-day simple moving average of $14.53. Sotera Health has a one year low of $10.71 and a one year high of $17.44.

Sotera Health (NASDAQ:SHC - Get Free Report) last posted its quarterly earnings data on Tuesday, November 5th. The company reported $0.17 EPS for the quarter, missing analysts' consensus estimates of $0.18 by ($0.01). The firm had revenue of $285.47 million for the quarter, compared to analysts' expectations of $278.64 million. Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. Sotera Health's quarterly revenue was up 8.5% compared to the same quarter last year. During the same period in the prior year, the company posted $0.18 earnings per share. As a group, sell-side analysts predict that Sotera Health will post 0.61 earnings per share for the current year.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.